insights_auto
Why is ALNOV down 2,39%?
Dive Deeperchevron_right
ALNOV:EPA
Novacyt SA
0,43 €
arrow_downward
-2,39%(-0,010) 1D
20-ноя., 10:32:52 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,43 €
High
0,44 €
Low
0,43 €
Mkt. cap
31,10 млн
Avg. vol.
128,00 миң
Volume
12,54 миң
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
Open
0,43 €
High
0,44 €
Low
0,43 €
Mkt. cap
31,10 млн
Avg. vol.
128,00 миң
Volume
12,54 миң
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
News stories
From web sources and news partners
The Motley Fool
·
48 мүнөт мурун
Nvidia Has Lost More Than the Market Value of 495 S&P 500 Companies in 6 Weeks -- and Its Downtrend May Be Just Beginning
BeInCrypto
·
54 мүнөт мурун
S&P 500 Logs Its Longest Losing Streak Since 2024. Here’s What Happened Last Time
Yahoo Finance
·
25 мүнөт мурун
Stock market today: Dow, S&P 500, Nasdaq futures continue to sell-off after Anthropic IPO fails to quell AI worries
Investing.com
·
1 саат мурун
S&P 500 Breaks Support as Global Risk Sentiment Begins to Crack
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
Founded2006-ж., 3-июл.
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com